Mefloquine Lawsuit Updates

Mefloquine Lawsuit Canada – Join the Mefloquine Lawsuit

The Current Mefloquine Action

The Canadian government required members of the Canadian Armed Forces to take Mefloquine when they knew or should have known that it could cause serious and permanent disability. As a result, many military members have suffered debilitating and long-term effects. 

The action against the Canadian government aims to hold it responsible by helping the veterans obtain financial compensation for the pain and suffering they have experienced.

The action is a mass tort, which means each veteran’s claim proceeds separately on an individual basis.

I Want to Participate

If you or someone you know experienced side effects from taking Mefloquine while in the Canadian Armed Forces, we can help you achieve compensation for the pain and suffering you experienced. To better understand your legal rights and how you may benefit from participating in this mass tort action against the Canadian government, please contact us at 1-877-771-7006 for a free consultation. 

Updates on Litigation

September 18, 2020 – Jurisdiction Motion:

Earlier this week, the Federal Court granted the motion of the Federal Government, and have stayed our cases in the Federal Court. We are now contemplating whether we should launch an appeal.

As many of you will recall, the legal team has always been of the view that the motion was just an attempt by the Federal Government to stall the litigation. The decision of the Federal Court does not stop the litigation. Your case is still moving forward whether it is in the Federal Court or the Superior Court of Justice.

We will provide an update as to our future course of action shortly. Nothing further is required from our clients at this time.

Decision on Jurisdiction Motion, dated September 16, 2020

July 27, 2020 – Jurisdiction Motion:

A half-day motion was originally scheduled for April 23, 2020 at the Federal Court. The issue in this motion was whether or not the case would remain in Federal Court. The Federal Government had asked for a stay of the case in Federal Court as it intends to add Hoffmann-Laroche to the litigation. However, due to COVID-19, the motion was rescheduled to May 27, 2020.

All parties appeared via video conference on May 27, 2020 and made submissions to the presiding Prothonotary.

We continue to await the decision of the Prothonotary and will provide updates as soon as the decision is released.

November 25, 2019:

Click here to read this update on Canada’s first formal response to the Plaintiffs’ claims.

August 16, 2019:

Click here to read this update from the first case conference regarding the Mefloquine Mass Tort.

September 30, 2019:

Click here to read this update on developments in the case.

October 18, 2019:

General Romeo Dallaire joins the Mass Tort

Your Story

Suffering from serious complications due to Mefloquine? Tell us your story.

Call Today

Suffering from complications from Mefloquine? You may qualify to join the Mefloquine Lawsuit in Canada.